TransMedics to Participate in Upcoming Virtual Investor Conferences
TransMedics Group, Inc. (NASDAQ: TMDX) announced its participation in two virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TransMedics Group, Inc. (NASDAQ: TMDX) announced its participation in two virtual investor conferences. The management team will attend the Oppenheimer Fall MedTech Summit on November 12, 2020, and the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020. These events will consist of 1x1 meetings only, with no webcasts available. TransMedics is a leader in portable extracorporeal warm perfusion for organ transplantation, focusing on enhancing organ quality and viability for patients with end-stage organ failure.
Details
News Market Reaction – TMDX
The recorded move for TMDX in the trading session of this news was -3.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANDOVER, Mass., Oct. 29, 2020 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, announced today that members of the management team will be virtually participating in two upcoming investor conferences. TransMedics will participate in the Oppenheimer Fall MedTech Summit on November 12, 2020, followed by the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020.
Event: Oppenheimer Fall MedTech Summit
Format: 1x1 Meetings
Date: Thursday, November 12, 2020
Event: Canaccord Genuity Virtual MedTech & Diagnostics Forum
Format: 1X1 Meetings
Date: Thursday, November 19, 2020
As management will be participating in 1x1 meeting only, no webcasts will be available.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung and liver failure.
View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-to-participate-in-upcoming-virtual-investor-conferences-301163404.html
SOURCE TransMedics Group, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.